Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Top Upgrades
- Cowen & Co. upgraded QUALCOMM Incorporated (NASDAQ:QCOM) from Market Perform to Outperform. Qualcomm shares rose 1.68 percent to $66.50 in pre-market trading.
- Analysts at William Blair upgraded Vital Therapies, Inc. (NASDAQ:VTL) from Market Perform to Outperform. Vital Therapies shares fell 1.22 percent to close at $8.10 on Friday.
- Raymond James upgraded WPX Energy, Inc. (NYSE:WPX) from Outperform to Strong Buy. WPX Energy shares fell 4.30 percent to close at $18.68 on Friday.
- Cowen & Co. upgraded Applied Materials, Inc. (NASDAQ:AMAT) from Market Perform to Outperform. Applied Materials shares rose 1.35 percent to $49.50 in pre-market trading.
- Atlantic Equities upgraded Comcast Corporation (NASDAQ:CMCSA) from Neutral to Overweight. Comcast shares rose 1.02 percent to $35.77 in pre-market trading.
- Goldman Sachs upgraded Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) from Sell to Buy. Intercept Pharmaceuticals shares rose 6.4 percent to $103.50 in pre-market trading.
- Buckingham upgraded Square, Inc. (NYSE:SQ) from Neutral to Buy. Square shares rose 2.08 percent to $69.78 in pre-market trading.
- Needham upgraded Allot Communications Ltd. (NASDAQ:ALLT) from Hold to Buy. Allot Communications shares gained 3.44 percent to $5.42 in pre-market trading.
- Wells Fargo upgraded PG&E Corporation (NYSE:PCG) from Market Perform to Outperform. PG&E shares climbed 1.96 percent to $43.80 in pre-market trading.
- Citigroup upgraded HMS Holdings Corp. (NASDAQ:HMSY) from Neutral to Buy. HMS Holdings shares rose 16.25 percent to close at $28.90 on Friday.
Top Downgrades
- Stifel Nicolaus downgraded Casella Waste Systems, Inc. (NASDAQ:CWST) from Buy to Hold. Casella Waste shares fell 1.83 percent to $27.85 in pre-market trading.
- Piper Jaffray downgraded ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) from Overweight to Neutral. ACADIA Pharmaceuticals shares fell 3.35 percent to $14.71 in pre-market trading.
- BMO Capital downgraded Horizon Pharma Public Limited Company (NASDAQ:HZNP) from Outperform to Market Perform. Horizon Pharma shares fell 1.16 percent to close at $17.97 on Friday.
- Raymond James downgraded CNX Resources Corporation (NYSE:CNX) from Market Perform to Underperform. CNX Resources shares rose 1.27 percent to close at $15.95 on Friday.
- Barclays downgraded Intel Corporation (NASDAQ:INTC) from Overweight to Equal-Weight. Intel shares fell 1.57 percent to $48.85 in pre-market trading.
- Jefferies downgraded CommScope Holding Company, Inc. (NASDAQ:COMM) from Buy to Hold. CommScope shares rose 0.13 percent to close at $31.64 on Friday.
- Bank of America downgraded Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) from Buy to Neutral. Pacira Pharmaceuticals shares rose 5.12 percent to close at $45.20 on Friday.
- JMP Securities downgraded Insmed Incorporated (NASDAQ:INSM) from Market Outperform to Market Perform. Insmed shares dropped 2.68 percent to $25.45 in pre-market trading.
- Goldman Sachs downgraded Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) from Buy to Neutral. Madrigal Pharmaceuticals shares fell 0.16 percent to close at $250.93 on Friday.
- Mizuho downgraded Noble Energy, Inc. (NYSE:NBL) from Buy to Neutral. Noble Energy shares fell 7.92 percent to close at $32.89 on Friday.
Top Initiations
- Piper Jaffray initiated coverage on Sage Therapeutics, Inc. (NASDAQ:SAGE) with an Overweight rating. The price target for Sage Therapeutics is set to $206. Sage Therapeutics shares closed at $145.68 on Friday.
- Analysts at Piper Jaffray initiated coverage on Global Blood Therapeutics, Inc. (NASDAQ:GBT) with an Overweight rating. The price target for Global Blood Therapeutics is set to $80. Global Blood Therapeutics shares closed at $46.55 on Friday.
- Piper Jaffray initiated coverage on Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR) with an Overweight rating. The price target for Alder Biopharmaceuticals is set to $28. Alder Biopharmaceuticals shares closed at $19.00 on Friday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!